AI
Friday, April 20, 2018 12:39:03 PM
What does Dr. Liau see to be able to make the very recent comment that autologous tumor lysate pulsed dendritic cells (aka: DCVax-L) are the most promising immunotherapy for GBM? Pretty bold. She probably had the statistics on everyone that has ever been given a dose of DCVax-L for GBM outside the formal Phase III trial. That is a lot of patients. She also had the blinded Phase III data. I suggest shorts brace, brace, brace. 
Respect Risk. Conduct Your Own Due Diligence. Manage your assets wisely. Diversify.
